Get 3 COPAY ASSISTANCE PROGRAM ONLY ENROLLMENT HOW TO ENROLL The Entyvio Connect CoPay Assistance

Entyvio is a biologic drug that's available only as a brand-name medication. It doesn't come in a biosimilar form.

The cost for Entyvio intravenous powder for injection 300 mg is around $8,619 for a supply of 1 powder for injection, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans.

Different parts of Medicare may cover portions of the cost of Entyvio. For example, if you have a Part D plan, it may cover the Entyvio injection price. If you have Medicare Part B, it may cover your visit to your doctor's office or clinic where you receive your infusion.

Entyvio has an average rating of 5.6 out of 10 from a total of 65 reviews for the treatment of Ulcerative Colitis. 40% of reviewers reported a positive experience, while 37% reported a negative experience.

Every patient reacts differently to medication treatment and has a different level of disease severity. Not every patient will respond to Entyvio. If after 14 weeks you have not experienced a therapeutic benefit with Entyvio your doctor may consider discontinuing Entyvio treatment.

ENTYVIO binds to a protein on the GI-directed white blood cells, keeping them from entering the GI tract. Now, GI-directed white blood cells continue moving through the bloodstream. With fewer white blood cells in the GI tract, ENTYVIO helps reduce inflammation and symptoms of ulcerative colitis or Crohn's disease.

The Start Program provides Entyvio at no cost to eligible new-to-therapy patients who have received a prior authorization denial from their commercial payer. Patients eligible for federal or state healthcare programs (Medicare, Medicaid, TRICARE, etc.) are ineligible.

Entyvio (vedolizumab) is an expensive intravenous (IV) medication used for ulcerative colitis or Crohn's disease. ing to the manufacturer, the list price for a 30-day supply of Entyvio is $3,363.82 or $40,365.84 per year.